Search

everythinglearnresearchcommunity

for

Search:↓

Glucocorticoid treatment in lupus can cause oral lesions, which need early diagnosis and comprehensive care.

Intravenous cyclophosphamide effectively treated steroid-resistant lupus cystitis and peritonitis.

Micelles can change cetirizine's ionization, affecting its effectiveness in treatments.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

Surgical excision is the best treatment for SCC.

Most clinicians follow discharge guidelines, many lupus patients don't use sunscreen regularly, dithranol is effective for psoriasis, biopsy methods should be based on lesion type, voriconazole may raise skin cancer risk, a new scale can help diagnose female hair loss early, and most melanomas may develop from existing moles.

High-dose UVA-1 therapy improves symptoms and skin condition in sclerosing skin disease.

The cosmetic product improved melasma and skin quality without causing irritation.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Choosing the right patients, using proper techniques, and having thorough knowledge are key to preventing and managing dermal filler complications.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Fibromyalgia slightly more common in SLE patients but doesn't affect SLE activity assessments.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

Pegvaliase is recommended for treating adults with phenylketonuria.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

Targeting abnormal lung fluid metabolism could reduce COVID-19 deaths and ventilator use.

The 308-nm excimer laser is a promising treatment for vitiligo with varying success and mild side effects.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.